Literature DB >> 34109885

SARS-CoV2 spike protein gene variants with N501T and G142D mutation-dominated infections in mink in the United States.

Hugh Y Cai1, Allison Cai2.   

Abstract

Large numbers of mink have been infected with SARS-CoV2 containing the spike protein Y453F mutation in Europe, causing zoonosis concerns. To evaluate the genetic characteristics of the U.S. and Canadian mink-derived SARS-CoV2 sequences, we analyzed all animal-derived (977) and all Canadian (19,529) and U.S. (173,277) SARS-CoV2 sequences deposited in GISAID from December 2019 to March 12, 2021, and identified 2 dominant novel variants, the N501T-G142D variant and N501T-G142D-F486L variant, in the U.S. mink-derived SARS-CoV2 sequences. These variants were not found in mink from Canada or other countries. The Y453F mutation was not identified in the mink-derived sequences in the United States and Canada. The N501T mutation occurred 2 mo earlier in humans than in mink in the United States, and the novel N501T-G142D and N501T-G142D-F486L variants were found in humans prior to mink. Our results suggest that the novel SARS-CoV2 variants may have evolved during human infection and were then transmitted to mink populations in the United States.

Entities:  

Keywords:  COVID-19; N501T; N501Y; SARS-CoV2; mink; spike protein; variant

Year:  2021        PMID: 34109885     DOI: 10.1177/10406387211023481

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.

Authors:  Emily K Makowski; John S Schardt; Matthew D Smith; Peter M Tessier
Journal:  PLoS Comput Biol       Date:  2022-05-31       Impact factor: 4.779

2.  An Electrostatically-steered Conformational Selection Mechanism Promotes SARS-CoV-2 Spike Protein Variation.

Authors:  Marija Sorokina; Jaydeep Belapure; Christian Tüting; Reinhard Paschke; Ioannis Papasotiriou; João P G L M Rodrigues; Panagiotis L Kastritis
Journal:  J Mol Biol       Date:  2022-05-17       Impact factor: 6.151

3.  Analysis of SARS-CoV-2 Variants From 24,181 Patients Exemplifies the Role of Globalization and Zoonosis in Pandemics.

Authors:  Philippe Colson; Pierre-Edouard Fournier; Hervé Chaudet; Jérémy Delerce; Audrey Giraud-Gatineau; Linda Houhamdi; Claudia Andrieu; Ludivine Brechard; Marielle Bedotto; Elsa Prudent; Céline Gazin; Mamadou Beye; Emilie Burel; Pierre Dudouet; Hervé Tissot-Dupont; Philippe Gautret; Jean-Christophe Lagier; Matthieu Million; Philippe Brouqui; Philippe Parola; Florence Fenollar; Michel Drancourt; Bernard La Scola; Anthony Levasseur; Didier Raoult
Journal:  Front Microbiol       Date:  2022-02-07       Impact factor: 5.640

Review 4.  A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations.

Authors:  Chiranjib Chakraborty; Ashish Ranjan Sharma; Manojit Bhattacharya; Sang-Soo Lee
Journal:  Front Immunol       Date:  2022-02-09       Impact factor: 7.561

Review 5.  Ecological super-spreaders drive host-range oscillations: Omicron and risk space for emerging infectious disease.

Authors:  Walter A Boeger; Daniel R Brooks; Valeria Trivellone; Salvatore J Agosta; Eric P Hoberg
Journal:  Transbound Emerg Dis       Date:  2022-05-13       Impact factor: 4.521

6.  Comparison of BNT162b2-, mRNA-1273- and Ad26.COV2.S-Elicited IgG and Neutralizing Titers against SARS-CoV-2 and Its Variants.

Authors:  Nigam H Padhiar; Jin-Biao Liu; Xu Wang; Xiao-Long Wang; Brittany H Bodnar; Shazheb Khan; Peng Wang; Adil I Khan; Jin-Jun Luo; Wen-Hui Hu; Wen-Zhe Ho
Journal:  Vaccines (Basel)       Date:  2022-05-27

Review 7.  The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies.

Authors:  Daniele Focosi; Scott McConnell; Arturo Casadevall
Journal:  Drug Resist Updat       Date:  2022-10-03       Impact factor: 22.841

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.